Advancing early detection of organ damage and cardiovascular risk prevention: the Suzhou cardiometabolic health study protocol - exploring the role of oral microbiome and metabolic profiling in risk stratification
BackgroundCardiovascular Disease (CVD) is the leading cause of global mortality, with its incidence rate rising year by year due to the prevalence of metabolic diseases. Existing primary and secondary prevention strategies for cardiovascular disease have limitations in identifying some high-risk gro...
Saved in:
Main Authors: | Mengmeng Zhu, Yiwen Li, Wenting Wang, Longkun Liu, Wenwu Liu, Jiayu Yu, Qian Xu, Jing Cui, Yanfei Liu, Keji Chen, Yue Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1522756/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Machine learning-based plasma metabolomics for improved cirrhosis risk stratification
by: Jingru Song, et al.
Published: (2025-02-01) -
The influence of menopause age on gynecologic cancer risk: a comprehensive analysis using NHANES data
by: Yiliminuer Abulajiang, et al.
Published: (2025-02-01) -
Identification of specific risk factors and predictive analytics for cardio-cerebral arterial stenosis: a comparative study utilizing framingham risk stratification insights
by: Gege Zhang, et al.
Published: (2025-02-01) -
Oakland score to identify low-risk patients with lower gastrointestinal bleeding performs well among emergency department patients
by: Daniel D. DiLena, et al.
Published: (2025-02-01) -
The role of the TAPSE/sPAP ratio as a predictor of mortality in Pulmonary Arterial Hypertension: Its value for patient risk stratification
by: Paul Palacios-Moguel, MD, et al.
Published: (2025-02-01)